← Back to headlines
Novartis Faces Competition from Copycat Drugs
Pharmaceutical giant Novartis is experiencing increased pressure from generic, copycat drugs. This competition is impacting the company's market share and profitability.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
